Elotuzumab
AbbVie,BMS
['mmsm', 'krd ']
#asco23 #mmsm mrd negativity and vgpr was achieved in 145 of e-krd (49.8%) and 102 (35.4%) of krd patients, respectively (p=.0005). data per imwg vs not following criteria 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities